Abbott Laboratories (NYSE:ABT) is one of the top 10 defensive stocks to consider in a volatile market. On July 3, analysts at ...

Abbott Laboratories’ Debt totaled $15 Bil at the end of the latest quarter, while its market capitalization stands at $233 ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

With a market cap of $233.8 billion, Abbott Laboratories (ABT) is a global healthcare company that discovers, develops, ...

The main point of investing for the long term is to make money. Better yet, you'd like to see the share price move ...

Key collaborations enable Abbott to increase its global presence and accessibility to patients who haven't used CGMs before.

This was the stock's second consecutive day of losses.